Back to ARNA Stock Lookup

ARNA Related Corporate News

May 7, 2013 03:36 PM Arena (ARNA) Confirms BELVIQ Will Soon Be Available for Sale in the U.S.

May 3, 2013 09:20 AM VIVUS (VVUS) to Report Q1 Results May 8th; Focus on Promotions vs. New Rx

Apr 5, 2013 08:03 AM Arena Pharma (ARNA) Commences APD334 Phase 1 for S1P1

Apr 1, 2013 08:04 AM Arena (ARNA) Reports Submission of BELVIQ Market App in Mexico

Feb 25, 2013 09:20 AM Arena (ARNA): Eisai Discloses $199.50/Bottle Acquisition Cost of Belviq 10-mg Tabs

Jan 22, 2013 08:04 AM Arena Pharma (ARNA) Receives Day 180 from CHMP for Belviq

Nov 6, 2012 04:03 PM Arena Pharma (ARNA) Enters Marketing, Supply Agreement for Belviq

Oct 12, 2012 08:01 AM Arena Pharma (ARNA) Commences APD811 Phase 1

Sep 18, 2012 08:05 AM Arena Pharma (ARNA) to Present at UBS GLS Conference on Sept. 22nd

Jul 18, 2012 09:08 AM VIVUS' (VVUS) Qsymia Approved and has Advantages Over Belviq

Jul 11, 2012 04:06 PM Arena Pharma (ARNA) Files MAA for Lorcaserin with Swissmedic

Jun 27, 2012 04:17 PM Arena (ARNA) Gets FDA Ok for Potential Blockbuster Fat Pill

Jun 27, 2012 01:16 PM Arena (ARNA) Confirms FDA Approval of BELVIQ

Jun 27, 2012 12:52 PM Arena (ARNA), Eisai win FDA approval for diet pill lorcaserin

May 16, 2012 09:04 AM Arena Pharmaceuticals (ARNA) Prices 11M Offering at $5.50/Share

May 10, 2012 05:06 PM Arena Pharma (ARNA) Confirms FDA Panel Voted Benefits of Lorcaserin Outweigh Risks

May 10, 2012 08:28 AM With Arena Pharmaceuticals (ARNA) Halted Ahead of AdCom, There Will Be Other Ways to Play...

May 7, 2012 03:52 PM MarketWire Corrects Erroneous Arena Pharma (ARNA) Release

Apr 10, 2012 05:20 PM Arena Pharma (ARNA) Registers to Sell 8.63M Shares for Deerfield

Mar 29, 2012 03:38 PM FDA Panel Votes 17-6 Obesity Drugmakers Should Study Heart Risks; Watch Orexigen (OREX, VIVUS (VVUS), Arena (ARNA)

Jan 11, 2012 06:12 AM Arena Pharma (ARNA) Enters $33M Financing Agreement with Deerfield Management

Jan 10, 2012 08:04 AM Arena Pharma (ARNA) says FDA accepts resubmission of Lorcaserin NDA; sets PDUFA date as June 27th, 2012

Oct 3, 2011 09:32 AM Arena Pharma (ARNA) Presents New Phase 3 Data for Lorcaserin on Cardiac Valvular Regurgitation

Jul 12, 2011 08:05 AM Arena (ARNA) Updates on APD811 Phase 1 in PAH Treatment

May 26, 2011 06:58 AM Arena Pharma (ARNA) Reports Lorcaserin Caused 'Statistically Significant' Weight Loss in Recent Phase 3

Mar 29, 2011 06:44 AM Arena Pharma (ARNA) Enters $35.5M Private Placement

Mar 10, 2011 08:47 AM Arena Pharma (ARNA) Receives Reissue Patent for GPR119 Receptor ID Compounds

Jan 27, 2011 04:08 PM Arena Pharmaceuticals (ARNA) Cuts U.S. Workforce By 25%

Nov 9, 2010 07:49 AM Arena Pharma (ARNA) and Eisai Announce Significant Results in Lorcaserin BLOOM-DM Trial

Oct 25, 2010 07:15 AM Arena Pharma (ARNA) and Eisai Receive Complete Response for Lorcaserin NDA; FDA Cannot Approve Application in Present Form

Oct 20, 2010 08:32 AM Arena Pharma (ARNA) Announces Results of APD916 Phase 1; A Lower Dose May be Sufficient

Sep 16, 2010 04:54 PM Arena Pharma (ARNA) shares to resume trading at 5:05pm ET

Sep 16, 2010 03:07 PM Arena (ARNA) Fails to Win Backing of FDA Panel for Lorcaserin Diet Pill

Sep 16, 2010 07:17 AM Arena Pharma (ARNA) Shares Halted as FDA Panel Set to Review Lorcaserin Today

Jul 14, 2010 05:02 PM New England Journal Shows Arena Pharma's (ARNA) lorcaserin Beats Placebo in 2-Year BLOOM Trial

Jul 1, 2010 07:23 AM Arena Pharma (ARNA) Selects Eisai to Market Lorcaserin in the U.S.

Jun 2, 2010 08:12 AM Arena Pharma (ARNA) Announces Meeting with U.S. FDA Regarding Lorcaserin NDA

Mar 24, 2010 08:05 AM Arena Pharmaceuticals (ARNA) Initiates Phase 1 Clinical Trial of APD916 for Narcolepsy and Cataplexy

Feb 26, 2010 08:11 AM Arena Pharma (ARNA) Gets PDUFA from U.S. FDA for Lorcaserin NDA

Feb 24, 2010 08:15 AM Arena Pharma (ARNA) Lorcaserin NDA Accepted for Filing by U.S. FDA

Dec 23, 2009 04:09 PM Arena Pharma (ARNA) Announces Merck (MRK) Discontinues Development of MK-1903

Oct 26, 2009 07:30 AM Arena Pharma (ARNA) Reports Pivotal BLOOM Phase III data

Oct 12, 2009 08:49 AM Obesity 2009 to Feature Multiple Presentations of Arena Pharma's (ARNA) Lorcaserin

Sep 18, 2009 03:18 PM Arena Pharmaceuticals (ARNA) To Present at UBS Global Life Sciences Conference on Sept 23, 2009

Sep 18, 2009 07:48 AM Arena Pharmaceuticals (ARNA) Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track

Jun 17, 2009 08:52 AM Arena Pharma (ARNA) Agrees to Receive $100M from Deerfield Management

Jun 8, 2009 07:54 AM Arena Pharmaceuticals (ARNA) Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss

Mar 30, 2009 08:23 AM Arena Pharmaceuticals (ARNA) Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints

Mar 23, 2009 04:38 PM Arena Pharmaceuticals (ARNA) Obtains $50 Million Equity Financing Commitment

Dec 9, 2008 04:58 PM Arena Pharma (ARNA) Reports Preliminary Results from Phase 2b Trial of APD125 for Insomnia

Back to ARNA Stock Lookup